I thank Jeremy Miles for that question. The Welsh Government commissioned Public Heath Wales to examine the latest evidence. Of course, that will help to inform the appraisal to be undertaken by the All-Wales Strategy Medicines Group, our independent expert body that provides advice to Ministers in Wales on new medications not yet considered by NICE, the National Institute for Health and Care Excellence, next month. It will consider the clinical and cost-effectiveness of the medication. So, it’s inappropriate to comment further at this stage, but, of course, the Cabinet Secretary for Health, Well-being and Sport will update Members once he’s received and considered advice from the All-Wales Medicines Strategy Group.